Navigation Links
PPTA Opposes Tax on Blood Clotting Factor
Date:6/15/2011

ANNAPOLIS, Md., June 15, 2011 /PRNewswire/ -- PPTA opposes New Jersey Assembly Bill 2003 passed by the New Jersey Assembly Appropriations Committee on June 13 that imposes a new tax on therapies used to treat bleeding disorders like hemophilia.

The bill creates The Bleeding Disorders Treatment Fund by taxing the manufacturers of blood clotting factor in the form of a 6 percent rebate. PPTA opposes any policy that would impose a tax on the sale of lifesaving therapies. PPTA calls on the pharmaceutical industry at large to keep a close watch on this bill, which is a slippery slope towards taxing other medicines.

Blood clotting factor is a highly complex, lifesaving therapy that treats rare, genetic bleeding disorders such as hemophilia. This tax would be the first of its kind in the country where a state government would tax one type of business that provides a service for patients and subsequently gives the tax proceeds to other businesses that provide services to those same patients.

"This 'rebate' is nothing more than the tax on clotting factor sales that was proposed and failed in the last session," said Julie Birkofer, senior vice president, North America, PPTA. "It sets a dangerous precedent that could have a negative impact on patient access to clotting factor."

Plasma protein therapies, which include plasma-derived therapies and recombinant blood clotting factors (a biotechnology product), are biological products that are not interchangeable, and no generics or substitutions exist. These unique therapies are used every day to treat people with bleeding disorders such as hemophilia, which causes painful internal bleeding and debilitating joint damage; primary immunodeficiency diseases, which render the body defenseless from even the most common infections, often leading to pneumonia and other serious illnesses; and alpha-1 antitrypsin deficiency, also known as genetic chronic obstructive pulmonary disease (COPD). Additionally, al
'/>"/>

SOURCE Plasma Protein Therapeutics Association (PPTA)
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. To Reach, Perchance to Kill the Cancer: A Soliloquy From Epeius Nanotechnologies Opposes That Sea of Troubles
2. MDMA Board Unanimously Opposes Medical Device Tax
3. Regulus Therapeutics and Collaborators from NYU Langone Medical Center Publish New Data Demonstrating Clearance of Cholesterol from Bloodstream and Reduction of Atherosclerotic Plaques through Inhibition of microRNA-33
4. MD Anderson and Biocept Scientists to Present Poster at ASCO on Disseminated Tumor Cells (DTCs) in Bone Marrow and Circulating Tumor Cells (CTCs) in Blood in Early Stage Breast Cancer Patients
5. FDA: Treatment With Angiotensin Receptor Blockers for High Blood Pressure Does Not Increase Risk of Cancer
6. EMIT Corporation Receives FDA 510(k) Clearance for HypothermX™ Blood and Fluid Warmer.
7. OVA1 Improves Ovarian Cancer Detection Over CA 125 Blood Test and Clinical Assessment
8. The Childrens Hospital of Philadelphia Partners with Vascular Magnetics, Inc. to Pursue Commercial Potential of Blood Vessel Research
9. New Device to Support Blood Circulation for Heart Patients Shows Improved Outcomes Compared to Current Treatment
10. HERCULES Trial Demonstrates Significant Reduction in Systolic Blood Pressure While Revealing Marker in Hypertensive Patients Does Not Predict Outcomes of Renal Artery Stenting
11. Resource Now Available to Help Clinicians Reduce Risk of Blood Exposure from Short Peripheral IV Catheter Insertion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... 29, 2014  The BioFusionary Corporation, Inc. (TBC), ... proprietary electromagnetic induction platform with aesthetic and surgical ... under which TBC will merge with ... an all-stock transaction. Upon completion of ... the Australian Stock Exchange under the code COT. ...
(Date:7/29/2014)... 29, 2014 Today, Frost & Sullivan ... Sullivan Best Practices Award for Customer Value Leadership. ... platform that connects digital health application developers, medical ... pharmaceutical companies, prevention and wellness companies, population health ... Each year, Frost & Sullivan presents this award ...
(Date:7/29/2014)... --  Health 2.0 announces Bernard Tyson , CEO ... Eric Topol , Patrick Soon-Shiong , and Samsung,s President ... Annual Fall Conference this coming Sept. 21-24 in ... is set to host the very first Wearable Tech Fashion ... Consumer Tech & Wearables: Powering Healthy Lifestyles. The panel ...
Breaking Medicine Technology:The BioFusionary Corporation, Inc. Announces Intent To Complete Reverse Takeover Of Australia-Based Continuation Investments Limited 2The BioFusionary Corporation, Inc. Announces Intent To Complete Reverse Takeover Of Australia-Based Continuation Investments Limited 3Frost & Sullivan Commends Validic for Delivering Superior Customer Value through its mHealth Interoperability Technology Platform 2Frost & Sullivan Commends Validic for Delivering Superior Customer Value through its mHealth Interoperability Technology Platform 3Frost & Sullivan Commends Validic for Delivering Superior Customer Value through its mHealth Interoperability Technology Platform 4Kaiser Permanente CEO to Keynote Health 2.0 8th Annual Fall Conference 2Kaiser Permanente CEO to Keynote Health 2.0 8th Annual Fall Conference 3
(Date:7/29/2014)... CRN International has promoted a longtime executive ... Upton, an 11-year veteran at the radio marketing company, ... managing the day-to-day execution of all CRN client campaigns. ... all activities for CRN clients, which include some ... The department interfaces directly with clients, sets project timelines ...
(Date:7/29/2014)... Somerset, NJ (PRWEB) July 29, 2014 ... drug development solutions and advanced delivery technologies for ... that Dr. Jeff Browne, R&D Director and US ... the Bioavailability of Absorption-Limited Drugs with Lipid-Based Formulations ... 30th Annual Meeting of the Japan Society of ...
(Date:7/29/2014)... 2014 TMG Health, the leading ... health plans in the Medicare Advantage, Medicare Part ... held its annual Client Forum at its National ... theme, “Partners in Excellence: Navigating the Post-Reform Landscape ... leaders from TMG Health’s Client base of Health ...
(Date:7/29/2014)... According to an article in the Daily ... a 52 year old woman in India. The surgery took ... had no idea that she had such a large tumor ... for years, but did not connect it to a possible ... the massive uterine fibroid after Latha was admitted for heavy ...
(Date:7/29/2014)... 2014 “Our years of experience ... fail to insulate their homes properly simply due ... preventing heat transfer and conduction,” Clean Crawls says ... recently released an article explaining exactly how ... energy bills. , To contact Clean Crawls for ...
Breaking Medicine News(10 mins):Health News:CRN International Names New Director to Lead Client Services Department 2Health News:Catalent Expert to Present on Enhancing Bioavailability of Poorly Absorbed Drugs at Japan Society of Drug Delivery Systems 2Health News:TMG Health Client Forum Explores Strategies for Success in the Post-Reform Market 2Health News:TMG Health Client Forum Explores Strategies for Success in the Post-Reform Market 3Health News:World’s Largest Uterine Fibroid Removed from Patient 2Health News:World’s Largest Uterine Fibroid Removed from Patient 3Health News:What’s The Point of Insulation? Clean Crawls Explains The Dangers of Heat Transfer in Recently Released Article 2
... some common symptoms, due to which physicians often tend to ... occurs when the tongue or throat muscles // relax too ... more than 50 times an hour during sleep, causing snoring ... seconds. The problem is twice as common in men, and ...
... who survive Hodgkin's disease are found to have a higher ... that is given for the same, a new research has ... lymph nodes and the other immune system organs. Researchers found ... breast cancer if they survived Hodgkin's lymphoma. Dr Lois B. ...
... National Hospital, Oslo and other collaborating Universities from many ... 20 years in 900 adults has found that // ... risk of oral cancer in smoking individuals by at ... of developing cardiovascular deaths, the study has found that ...
... worldwide are estimated to suffer from multiple sclerosis (MS), ... young adults, and has a significant impact on the ... an average reduction in relapse rates of 30% in ... to weekly., ,Data from the extension of a ...
... been a dream come true for the scientists who been ... Administration is expected to take an extra step ahead as ... cloned animals, as well as their offspring, are safe to ... to cloning techniques, with Canadian Scientists having proved themselves following ...
... answer for the prayers of millions of men suffering ... robotic arms promises sooner recovery, less pain, scarring and ... cancer is the second leading cause of death among ... Asian men. It is estimated that one in six ...
Cached Medicine News:Health News:Reversibility of symptoms of depression using CPAP in patients with obstructive sleep apnea 2Health News:NSAIDS, Reduces The Risk Of Oral Cancer But Causes Heart Attacks 2Health News:New Hope For Patients With Relapsing Multiple Sclerosis 2Health News:Complete Robotic Surgery To Revolutionize Surgical Treatment of Prostate Cancer 2
Specially designed wider jaws to help split soft nucleus, cross action, round handle, maximum opening 2.8 mm....
Cross action, round handle, maximum opening 2.8 mm....
Irrigating nucleus chopper, wedge-shaped inferior edge with, blunt tip, 0.6 mm dual sideports, 20 gauge....
Nucleus chopper. For bimanual nucleus division....
Medicine Products: